Roquefort Therapeutics : CEO Ajan Reginald
– 52 – VisitsRoquefort Therapeutics PLC (LSE: ROQ) (Roquefort or the “Company”) is a public company listed on the Main Market of the London Stock Exchange. Roquefort is a biotechnology company developing innovative anticancer drugs for the fast growing oncology market. Led by CEO Ajan Reginald, Roquefort has a portfolio of four preclinical cancer drugs and 46 registered patents.
|
|
| Rating (average) | |
|---|---|
| Business Website Address | |
| Service Category | |
| Business Phone Number | |
| Specialization |